| 000 | 01261 a2200361 4500 | ||
|---|---|---|---|
| 005 | 20250512211052.0 | ||
| 264 | 0 | _c19831008 | |
| 008 | 198310s 0 0 eng d | ||
| 022 | _a0002-9149 | ||
| 024 | 7 |
_a10.1016/0002-9149(83)90657-4 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aPickering, J E | |
| 245 | 0 | 0 |
_aClinical results with gemfibrozil. _h[electronic resource] |
| 260 |
_bThe American journal of cardiology _cAug 1983 |
||
| 300 |
_a39B-40B p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 |
_aCholesterol _xblood |
| 650 | 0 | 4 | _aCholesterol, HDL |
| 650 | 0 | 4 | _aCholesterol, LDL |
| 650 | 0 | 4 | _aClinical Trials as Topic |
| 650 | 0 | 4 | _aGemfibrozil |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHyperlipoproteinemias _xblood |
| 650 | 0 | 4 |
_aHypolipidemic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aLipoproteins, HDL _xblood |
| 650 | 0 | 4 |
_aLipoproteins, LDL _xblood |
| 650 | 0 | 4 |
_aLipoproteins, VLDL _xblood |
| 650 | 0 | 4 |
_aPentanoic Acids _xadverse effects |
| 650 | 0 | 4 |
_aTriglycerides _xblood |
| 650 | 0 | 4 |
_aValerates _xtherapeutic use |
| 773 | 0 |
_tThe American journal of cardiology _gvol. 52 _gno. 4 _gp. 39B-40B |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/0002-9149(83)90657-4 _zAvailable from publisher's website |
| 999 |
_c6351497 _d6351497 |
||